US › Healthcare

Certara Inc (CERT)

US · Healthcare · Health Information Services

$7.80-4.65%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$106.9M
Revenue YoY
+0.9%
Net profit
$-8.8M
Profit YoY
-284.8%
EPS
$0.09
EPS estimate
$0.11
Net margin
-8.2%

EPS came in at 0.09 against a street estimate of 0.11 — a miss of 18.2%.

Key statistics

Market cap
$1.26B
Forward P/E
12.7
P/B
1.24
Book value
$6.63
EPS (TTM)
$-0.10
52-week high
$13.88
52-week low
$4.45
50-day MA
$6.25
200-day MA
$7.58
Beta
1.46

Analyst view

Analysts rate Certara Inc a buy (5 buy, 6 hold, 0 sell out of 11) with an average price target of $7.53.

Shareholding

Insiders
2.68%
Institutions
110.00%

Largest institutional holders

FundStake
BlackRock Inc9.20%
Dimensional Fund Advisors, Inc.5.50%
Deerfield Management Co5.02%
Jefferies Financial Group Inc4.41%
Vanguard Portfolio Management, LLC3.84%
Vanguard Capital Management, LLC3.45%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)2.95%
Citadel Advisors Llc2.92%

Recent filings & reports

DocumentDate
Board / officer change · Q2 20262026-06-17
Shareholder vote results · Q2 20262026-05-15
Quarterly report · Q1 20262026-05-11
Results announced · Q2 20262026-05-11
Material agreement · Q2 20262026-04-22
Proxy statement · Q2 20262026-04-03
Annual report FY20252026-02-26
Quarterly report · Q3 20252025-11-06

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Certara Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.